NEW PSYCHOACTIVE SUBSTANCES. PHARMACOLOGY, CLINICAL, FORENSIC AND ANALYTICAL TOXICOLOGY

NEW PSYCHOACTIVE SUBSTANCES. PHARMACOLOGY, CLINICAL, FORENSIC AND ANALYTICAL TOXICOLOGY

Editorial:
SPRINGER
Año de edición:
Materia
Farmacia
ISBN:
978-3-030-10560-0
Páginas:
566
N. de edición:
1
Idioma:
Inglés
Disponibilidad:
Disponible en 2-3 semanas

Descuento:

-5%

Antes:

156,00 €

Despues:

148,20 €

1. Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures
2. Emergence, Diversity, and Control of New Psychoactive Substances: A Global Perspective
3. Self-Experiments with Psychoactive Substances: A Historical Perspective
4. Neuropharmacology of Synthetic Cathinones
5. Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances
6. The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins
7. The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonist New Psychoactive Substances: Evolution
8. Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action
9. Phencyclidine-Based New Psychoactive Substances
10. 1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances
11. Synthetic Opioids
12. Designer Benzodiazepines: Another Class of New Psychoactive Substances
13. Bioanalytical Methods for New Psychoactive Substances
14. Toxicokinetics of NPS: Update 2017
15. Epidemiology of NPS Based Confirmed Overdose Cases: The STRIDA Project
16. Patterns of Acute Toxicity Associated with New Psychoactive Substances
17. Fatal Poisonings Associated with New Psychoactive Substances
18. Wastewater Analysis for Community-Wide Drugs Use Assessment

This volume is designed to feature the pharmacology of new psychoactive substances, legislative aspects, information exchange including epidemiology, and clinical, forensic, and analytical toxicology in order to facilitate the understanding of this complex and rapidly developing phenomenon.

Features
• Gives an update of the multi-layered facets of the “designer drugs” phenomenon that exploded into public’s consciousness in the 2010s
• Offers diverse perspectives in areas of neuropharmacology, analytical toxicology, epidemiology of adverse events and information-exchange
• Provides accurate information about psychoactive recreational substances that transcended ‘traditional’ drugs of abuse.